Table 1 The baseline characteristics of patients who underwent baseline and follow-up sleep study
Parameter | Total (n = 28) median (min; max) | With SDB (n = 16) | Without SDB (n = 12) | p-value |
|---|---|---|---|---|
Age, years | 54.5 (27; 69) | 56.5 (46; 69) | 47 (27; 64) | p = 0.057 |
Sex (male), n (%) | 15 (54%) | 9 (56%) | 6 (50%) | χ2 = 0.32, p = 0.57 |
Hypertension duration, years | 16.5 (4; 36) | 18 (4; 33) | 18 (6; 35) | p = 0.76 |
Number of antihypertensive drugs | 4 (2; 7) | 4.5 (3; 7) | 4 (2; 5) | p = 0.049 |
BMI, kg/m2 | 30.0 (24.2; 44.2) | 30.2 (24.2; 44.2) | 30.0 (26.4; 33.6) | p = 0.76 |
Obesity, n (%) | 15 (54%) | 9 (56%) | 6 (50%) | χ2 = 0.26, p = 0.61 |
Type 2 diabetes mellitus, n (%) | 7 (25%) | 5 (31%) | 2 (17%) | χ2 = 0.23, p = 0.63 |
Dyslipidemia, n (%) | 22 (79%) | 14 (88%) | 8 (67%) | χ2 = 3.22, p = 0.073 |
Smoking, n (%) | 9 (32%) | 5 (31%) | 4 (33%) | χ2 = 0.44, p = 0.51 |
Chronic kidney disease, n (%) | 12 (43%) | 8 (50%) | 4 (33%) | χ2 = 1.85, p = 0.17 |
Contrast agent, | 75 (30; 200) | 88 (30; 200) | 65 (50; 200) | p = 0.85 |
Operation duration, min | 95 (40; 240) | 90 (40; 130) | 100 (45; 145) | p = 0.36 |
Radiofrequency bursts, number | 12 (6; 40) | 12 (6; 40) | 12 (9; 20) | p = 1.00 |
Hospitalization duration, bed-days | 4 (3; 6) | 4 (3; 6) | 4 (3; 6) | p = 0.93 |
Office heart rate, bpm | 71 (56; 98) | 67 (56; 98) | 75 (58; 88) | p = 0.96 |
Office SBP, mmHg | 165 (125; 221) | 169 (125; 221) | 160 (140; 178) | p = 0.23 |
Office DBP, mmHg | 100 (71; 138) | 100 (71; 138) | 100 (82; 116) | p = 0.49 |
Office pulse BP, mmHg | 65 (50; 117) | 68 (50; 117) | 60 (51; 75) | p = 0.68 |
Mean 24 h SBP, mmHg | 153 (104; 192) | 146 (104; 192) | 160 (127; 192) | p = 0.45 |
Mean 24 h DBP, mmHg | 89 (62; 125) | 79 (62; 125) | 94 (69; 115) | p = 0.78 |
Mean daytime SBP, mmHg | 157 (109; 202) | 153 (109; 196) | 163 (138; 202) | p = 0.49 |
Mean daytime DBP, mmHg | 92 (67; 131) | 88 (67; 131) | 95 (76; 124) | p = 0.68 |
Mean nighttime SBP, mmHg | 140 (99; 203) | 135 (99; 203) | 147 (109; 159) | p = 0.73 |
Mean nighttime DBP, mmHg | 79 (54; 114) | 71 (54; 114) | 87 (55; 95) | p = 0.91 |
Non-dipping 24-h SBP profile, n (%) | 11 (39%) | 9 (56%) | 2 (17%) | χ2 = 1.89, p = 0.17 |
Daytime BP load, % | 81 (0; 100) | 62 (0; 100) | 94 (14; 100) | p = 0.30 |
Nighttime BP load, % | 86 (0: 100) | 69 (0; 100) | 93 (13; 100) | p = 0.56 |
Creatinine, mcmol/l | 74 (50; 192) | 73.5 (56; 135) | 75 (50; 95) | p = 0.93 |
Creatinine postoperative, mcmol/l | 77 (47; 102) | 76.5 (47; 102) | 73 (48; 90) | p = 0.30 |
eGFR, ml/min/1.73 m2 | 89 (33; 114) | 89.5 (53; 109) | 94 (58; 114) | p = 0.64 |
Glucose, mmol/l | 5.7 (4.6; 8.4) | 5.6 (4.60; 8.40) | 5.7 (5.00; 6.50) | p = 0.80 |
Total cholesterol, mmol/l | 5.2 (3.9; 7.2) | 5.2 (3.90; 7.10) | 5.4 (4.2; 6.8) | p = 0.54 |
LDL-cholesterol, mmol/l | 3.3 (1.2; 4.5) | 3.3 (1.2; 4.5) | 3.64 (3.2; 4.1) | p = 1.00 |
ESS, score | 6 (3; 10) | 5.5 (3; 7) | 6 (3; 10) | p = 0.11 |